CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...